Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00060036" target="_blank" >RIV/00023001:_____/16:00060036 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15110/16:33160427
Result on the web
<a href="http://carcin.oxfordjournals.org/content/37/10/957.long" target="_blank" >http://carcin.oxfordjournals.org/content/37/10/957.long</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/carcin/bgw080" target="_blank" >10.1093/carcin/bgw080</a>
Alternative languages
Result language
angličtina
Original language name
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients
Original language description
Germline genetic variability might contribute, at least partially, to the survival of pancreatic ductal adenocarcinoma (PDAC) patients. Two recently performed genome-wide association studies (GWAS) on PDAC overall survival (OS) suggested (P < 10(-5)) the association between 30 genomic regions and PDAC OS. With the aim to highlight the true associations within these regions, we analyzed 44 single-nucleotide polymorphisms (SNPs) in the 30 candidate regions in 1722 PDAC patients within the PANcreatic Disease ReseArch (PANDoRA) consortium. We observed statistically significant associations for five of the selected regions. One association in the CTNNA2 gene on chromosome 2p12 [rs1567532, hazard ratio (HR) = 1.75, 95% confidence interval (CI) 1.19-2.58, P = 0.005 for homozygotes for the minor allele] and one in the last intron of the RUNX2 gene on chromosome 6p21 (rs12209785, HR = 0.88, 95% CI 0.80-0.98, P = 0.014 for heterozygotes) are of particular relevance. These loci do not coincide with those that showed the strongest associations in the previous GWAS. In silico analysis strongly suggested a possible mechanistic link between these two SNPs and pancreatic cancer survival. Functional studies are warranted to confirm the link between these genes (or other genes mapping in those regions) and PDAC prognosis in order to understand whether these variants may have the potential to impact treatment decisions and design of clinical trials.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GAP301%2F12%2F1734" target="_blank" >GAP301/12/1734: Analysis of role of genetic factors in pancreatic cancer risk and prognosis</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Carcinogenesis
ISSN
0143-3334
e-ISSN
—
Volume of the periodical
37
Issue of the periodical within the volume
10
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
957-964
UT code for WoS article
000386037100005
EID of the result in the Scopus database
—